10-QPeriod: Q3 FY2014

3M CO Quarterly Report for Q3 Ended Sep 30, 2014

Filed October 30, 2014For Securities:MMM

Summary

3M Company's (MMM) third quarter and first nine months of 2014 results show continued top-line growth driven by organic local-currency sales increases across all five business segments. For the third quarter, net sales increased 2.8% year-over-year to $8.1 billion, while operating income rose 9.4%. Diluted earnings per share (EPS) for the quarter were $1.98, an increase from $1.78 in the prior year period. The company demonstrated strong performance in its Health Care segment, which saw 4.7% sales growth, and positive momentum in the Industrial and Electronics & Energy segments. While foreign currency translation had a slight negative impact on sales, the company's diversified business model and focus on innovation continue to drive performance. Financial condition remains robust, supported by strong operating cash flows and access to capital markets. Key financial highlights include a notable increase in operating income margins to 23.4% in Q3 2014, up from 22.0% in Q3 2013, reflecting benefits from selling price increases, raw material cost decreases, and lower pension expenses. The company also repurchased a significant amount of its stock ($4.373 billion in the first nine months of 2014) and increased its dividend by 35%, underscoring its commitment to returning value to shareholders. Management is focused on strategic investments, including business transformation and ERP implementation, which are expected to strengthen the company for the future.

Financial Highlights

52 data points
Beta

Revenue

$8.14B

48.3% Gross Margin

Net Income

$1.30B

16.0% Net Margin

EPS (Diluted)

$1.98

Total Assets

$32.78B

Cash & Equivalents

$1.93B

Free Cash Flow

$1.34B

Financial Statements
Beta
Revenue$8.14B
Cost of Revenue$4.21B
Gross Profit$3.93B
SG&A Expenses$1.60B
Operating Expenses$6.24B
Operating Income$1.90B
Net Income$1.30B
EPS (Basic)$2.02
EPS (Diluted)$1.98
Shares Outstanding (Basic)645.30M
Shares Outstanding (Diluted)657.90M

Key Highlights

  • 1Q3 2014 net sales increased 2.8% to $8.1 billion, with organic local-currency sales up 3.9%.
  • 2Diluted EPS grew to $1.98 in Q3 2014 from $1.78 in Q3 2013.
  • 3Operating income increased by 9.4% in Q3 2014, with operating margins expanding to 23.4% from 22.0% year-over-year.
  • 4All five business segments (Industrial, Safety and Graphics, Electronics and Energy, Health Care, Consumer) reported positive organic local-currency sales growth.
  • 5The company repurchased $4.373 billion of its stock in the first nine months of 2014 and increased its quarterly dividend by 35%.
  • 6Operating cash flow for the first nine months of 2014 was $4.443 billion, an increase of $619 million compared to the prior year period.
  • 73M acquired Treo Solutions LLC in April 2014, strengthening its Health Care segment's data analytics capabilities.

Frequently Asked Questions

In the third quarter of 2014, 3M reported a 2.8% increase in net sales to $8.1 billion, driven by a 3.9% growth in organic local-currency sales across all segments. Operating income rose by 9.4% to $1.9 billion, leading to an expansion of operating margins to 23.4%. Diluted earnings per share increased to $1.98 from $1.78 in the prior year quarter.

All five business segments demonstrated positive organic local-currency sales growth. The Health Care segment led with 5.4% growth, followed by Electronics and Energy (4.3%), Industrial (4.2%), Consumer (3.1%), and Safety and Graphics (3.1%). This broad-based growth highlights the company's diversified product portfolio and market reach.

3M continued its commitment to returning value to shareholders by repurchasing $4.373 billion of its stock in the first nine months of 2014 under a new $12 billion authorization. Additionally, the company increased its quarterly dividend by 35%, marking the 56th consecutive year of dividend increases. The company is also strategically managing its capital structure, increasing its use of debt to optimize its cost of capital.

The company is involved in several ongoing legal proceedings, most notably product liability claims related to respirator masks/asbestos litigation, and environmental matters concerning perfluorinated compounds (PFCs) at several manufacturing sites. While the company has recorded accruals for certain liabilities, it notes that the ultimate outcomes and potential liabilities for some of these matters, particularly concerning environmental remediation and some pending litigation, cannot be reliably estimated at this time. The company believes its current accruals are adequate for probable and estimable liabilities.